Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy

Documenti analoghi

• Melnoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy
  di: Holtzhausen, Alisha, et al.
  Pubblicazione: (2015)
• Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy
  di: Holtzhausen, Alisha, et al.
  Pubblicazione: (2014)
• Early carcinogenesis involves the establishment of immune privilege via intrinsic and extrinsic regulation of Indoleamine 2,3-dioxygenase-1: Translational implications in cancer immunotherapy
  di: Alisha eHoltzhausen, et al.
  Pubblicazione: (2014-10-01)
• Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization
  di: Holtzhausen, Alisha, et al.
  Pubblicazione: (2013)
• Indoleamine 2,3-Dioxygenase and Dendritic Cell Tolerogenicity
  di: Harden, Jamie L., et al.
  Pubblicazione: (2012)